Financials
Financial year 2025
PHARMACIE DE LA SALM from Vielsalm, company number BE0449069121, closed financial year 2025 with a result of € 126,916 after tax. For that financial year PHARMACIE DE LA SALM recorded a gross margin of € 449,619 and equity of € 453,184. Compared with financial year 2024, the result moved from € 116,979 to € 126,916. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 453,184
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 126,916
▲ 8% vs 2024
Profit after tax over the fiscal year.
€ 200,755
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 70,000 paid out
55 % of the profit went to the shareholders, mostly to PHARMASALM (99 % of the shares). That is where the money ends up.
People and assets in 2025
4.2
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 250,161
▲ 8% vs 2024
€ 59,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,920
▼ 11% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 48,265
Loans from banks and other lenders, long and short.
€ 163,495
▼ 5% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 43,169
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 388,555 | € 429,718 | € 414,588 | € 449,619 | ▲ 8% |
| Profit after taxes | € 95,354 | € 129,544 | € 116,979 | € 126,916 | ▲ 8% |
| Equity | € 397,864 | € 398,909 | € 398,578 | € 453,184 | ▲ 14% |
| Total debts | € 310,175 | € 389,293 | € 342,420 | € 325,215 | ▼ 5% |
| Cash | € 191,828 | € 130,015 | € 181,494 | € 200,755 | ▲ 11% |
| Retained profit | € 335,364 | € 336,409 | € 336,078 | € 390,684 | ▲ 16% |
| Dividend | € 90,000 | € 126,250 | € 115,000 | € 70,000 | ▼ 39% |
| Bank debt | € 9,613 | € 0 | € 0 | € 48,265 | |
| Balance sheet total | € 708,039 | € 788,201 | € 740,998 | € 778,399 | ▲ 5% |
| Employees (FTE) | 4.1 | 4.1 | 4.1 | 4.2 | ▲ 0.1 |
Key figures of PHARMACIE DE LA SALM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE LA SALM?
What happened at PHARMACIE DE LA SALM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 126,916 (▲ 8% vs 2024). Source: NBB ↗
- ORPHELYA SRL became a director. NBB
- PHARMASALM SRL stepped down as director. NBB
- New establishment in Vielsalm. KBO
- Start of the company according to the CBE. KBO
In short
From € 95,354 profit in 2022 to € 126,916 profit in 2025.
Paid € 87,067 in corporate taxes since 2022.
Best year ever: 2023, with € 129,544 profit.
On average € 107,100 of value added per employee in 2025.
A new publication or filing at PHARMACIE DE LA SALM? We notify you, reason included.
Follow PHARMACIE DE LA SALMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PHARMASALM, ORPHELYA, VINCIMED comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DE LA SALMBehind PHARMACIE DE LA SALM is ORPHELYA SRL. The shares are held by PHARMASALM (99%), ORPHELYA (54.5%) and VINCIMED (44%).
Directors
According to the 2025 annual accounts
Director · represented by Dominique SIMON
since 2025
Director · represented by Dominique SIMON
· until 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue du Vieux-Marché 46
6690 Vielsalm
Rue du Vieux-Marché 48
6690 Vielsalm
Active since 14 April 1993
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0449.069.121
- VAT number
- BE 0449.069.121
- Registered office
- Rue du Vieux-Marché 46, 6690 Vielsalm
- Names & denominations
- PHARMACIE DE LA SALM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 1992
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten